Together with the differences in total and phospho-proteins detected in untreated cells or with E2 or FGF1, our data suggest a complex alteration in protein signaling dynamics in ER-positive breast tumors that can grow without estrogen in obesity. This evidence concerns the gene FGF1 and obesity disorder.